India’s COVID-19 Vaccine COVAXIN To Begin Phase 2 Study In September

India’s COVID-19 Vaccine COVAXIN To Begin Phase 2 Study In September

Preliminary results of the phase 1 human clinical trial suggest that India’s first indigenously developed vaccine against novel coronavirus, is safe, according to a report. COVAXIN, an inactivated vaccine against SARS-CoV-2 (the virus that causes COVID-19 disease), developed by Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) is expected to enter the next phase of testing next month.

Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.

Stay tuned for latest updates and in-depth analysis of news from India and around the world!

Download Mobile App from India’s No.1 News Video Publisher : https://indiatoday.app.link/zKoSVVDrnP

Follow us: Official website: https://www.indiatoday.in/

Twitter: https://twitter.com/IndiaToday

Facebook: https://www.facebook.com/IndiaToday


Go to Source